S-1 Filing

GUIDED THERAPEUTICS INC CIK: 924515

Filing Information

Form Type	S-1
Accession Number	`0001121781-13-000257`
Period End Date	20130331
Filing Date	20130705
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	gthp-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 98 Income Statement 68 Cash Flow Statement 131 Stockholders Equity 22

Balance Sheet 98 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$20.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18, $12 and $20 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`AccountsReceivableNet`	$166.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$64.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$44.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18, $12 and $20 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18, $12 and $20 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`AccountsReceivableNet`	$117.00K	USD	Point-in-time
Inventory, net of reserves of $44, $52 and $64 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$439.00K	USD	Point-in-time
Inventory, net of reserves of $44, $52 and $64 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Inventory, net of reserves of $44, $52 and $64 at March 31, 2013, December 31, 2012 and December 31, 2011 respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$520.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$247.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$54.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.96M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	100,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.89M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	65,492.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.26M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62,282.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	52,211.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.03M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62,282.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$361.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	52,211.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	65,492.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$386.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.62M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$4.31M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.58M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$30.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$61.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$25.00K	USD	Point-in-time
Current portion of long-term debt	`ShortTermBorrowings`	$100.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$362.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$419.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$878.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$436.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$757.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$453.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$65.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.73M	USD	Point-in-time
Long-term debt payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	$183.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	$4.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongtermDebtPayableLessCurrentPortion`	-	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$2.73M	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$1.72M	USD	Point-in-time
TOTAL LIABILITIES	`LongTermDebt`	$2.35M	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 65,492 and 62,282 shares issued and outstanding as of March, 31 2013 and December 31, 2012, respectively and 100,000 shares authorized and 52,211 shares issued and outstanding as of December 31, 2011	`CommonStockValue`	$52.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 65,492 and 62,282 shares issued and outstanding as of March, 31 2013 and December 31, 2012, respectively and 100,000 shares authorized and 52,211 shares issued and outstanding as of December 31, 2011	`CommonStockValue`	$66.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 65,492 and 62,282 shares issued and outstanding as of March, 31 2013 and December 31, 2012, respectively and 100,000 shares authorized and 52,211 shares issued and outstanding as of December 31, 2011	`CommonStockValue`	$62.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.61M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$95.81M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-85.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-93.91M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`TotalGuidedTherapeuticsStockholdersEquity`	$1.86M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`TotalGuidedTherapeuticsStockholdersEquity`	$1.13M	USD	Point-in-time
TOTAL GUIDED THERAPEUTICS STOCKHOLDERS' EQUITY	`TotalGuidedTherapeuticsStockholdersEquity`	$1.47M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$104.00K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.58M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.86M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$4.31M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.58M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$3.34M	USD	Annual
Contract and grant revenue	`Revenues`	$718.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$167.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$3.60M	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$72.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$25.00K	USD	Annual
Sales - devices and disposables	`SalesDevicesAndDisposables`	$132.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$106.00K	USD	Annual
Cost of goods sold	`CostOfGoodsSold`	$158.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$117.00K	USD	Annual
Gross Loss	`GrossProfit`	-	USD	1 Quarter
Gross Loss	`GrossProfit`	$-45.00K	USD	Annual
Gross Loss	`GrossProfit`	$-81.00K	USD	Annual
Gross Loss	`GrossProfit`	$-26.00K	USD	1 Quarter
Claim settlement	`ClaimSettlement`	$3.62M	USD	Annual
Claim settlement	`ClaimSettlement`	-	USD	1 Quarter
Claim settlement	`ClaimSettlement`	-	USD	Annual
Claim settlement	`ClaimSettlement`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$714.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.23M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$813.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.78M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$164.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$424.00K	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$70.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$287.00K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.58M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$930.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.92M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.71M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.57M	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.02M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$10.27M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-1.88M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-996.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.28M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-6.76M	USD	Annual
OTHER INCOME	`OtherIncome`	$192.00K	USD	Annual
OTHER INCOME	`OtherIncome`	$75.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	-	USD	Annual
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$80.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$17.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$72.00K	USD	Annual
INTEREST EXPENSE	`InterestExpense`	$15.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.81M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.01M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$4.35M	USD	Annual
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$6.64M	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-4.35M	USD	Annual
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLERS	`NetIncomeLoss`	$-6.64M	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.14	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	Annual
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	48,868.00	shares	Annual
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	63,671.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	52,471.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	57,429.00	shares	Annual

Cash Flow Statement 131 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.64M	USD	Annual
Bad debt expense (recovery)	`BadDebtRecovery`	$18.00K	USD	Annual
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	1 Quarter
Bad debt expense (recovery)	`BadDebtRecovery`	$-3.00K	USD	Annual
Bad debt expense (recovery)	`BadDebtRecovery`	$-16.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$112.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$361.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$75.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$34.00K	USD	Annual
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	$3.62M	USD	Annual
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	-	USD	1 Quarter
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	-	USD	Annual
Issuance of warrants in connection with settlement of claim	`IssuanceOfWarrantsInConnectionWithSettlementOfClaim`	-	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock based compensation	`ShareBasedCompensation`	$198.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$430.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$870.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-520.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$85.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$-4.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-88.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-65.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-50.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-24.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-49.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$8.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-144.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$113.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-239.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$187.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-337.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-225.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$121.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-413.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$25.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-126.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-70.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$513.00K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-168.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-30.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-180.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$84.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$55.00K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-177.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$502.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$299.00K	USD	Annual
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$3.91M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.19M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.31M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-3.67M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.73M	USD	Annual
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	-	USD	1 Quarter
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	-	USD	1 Quarter
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	-	USD	Annual
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	$640.00K	USD	60 Qtrs
Additions to capitalized software costs	`CapitalizedComputerSoftwareAdditions`	$-260.00K	USD	Annual
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-130.00K	USD	1 Quarter
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-444.00K	USD	Annual
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-101.00K	USD	1 Quarter
Additions to fixed assets	`AdditionsToNoncurrentAssets`	$-552.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-101.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-552.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-704.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-130.00K	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	$86.00K	USD	Annual
Proceeds from debt financing	`ProceedsFromIssuanceOfDebt`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.77M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$3.10M	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.65M	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$818.00K	USD	Annual
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$146.00K	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$125.00K	USD	Annual
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$215.00K	USD	Annual
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$169.00K	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$22.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.37M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$124.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.06M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.20M	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.16M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.07M	USD	Annual
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$65.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.27M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$183.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	$48.00K	USD	Annual
Cash paid for Interest	`InterestPaid`	$5.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$4.00K	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	Annual
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	Annual
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	Annual
Acquisition of minority interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$104.00K	USD	Annual
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	$162.00K	USD	Annual
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	-	USD	1 Quarter
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	$27.00K	USD	Annual
Conversion of accrued expenses into common stock	`ConversionOfAccruedExpensesIntoCommonStock`	-	USD	1 Quarter
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	-	USD	1 Quarter
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	-	USD	Annual
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	$50.00K	USD	Annual
Purchase of fixed assets by issuing notes payable	`PurchaseOfFixedAssetsByIssuingNotesPayable`	-	USD	1 Quarter
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	-	USD	1 Quarter
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	-	USD	1 Quarter
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	$63.00K	USD	Annual
Conversion of interest to principal	`ConversionOfInterestToPrincipal`	-	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	-	USD	1 Quarter
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	$2.66M	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	-	USD	Annual
Deemed dividends in the form of warrants to purchase common stock.	`DeemedDividendsInFormOfWarrantsToPurchaseCommonStock.`	-	USD	1 Quarter

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.01M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time
Issuance of common stock, Amount	`IssuanceOfCommonStockAmount`	$1.77M	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$818.00K	USD	Annual
Exercise of warrants/options, Amount	`ExerciseOfWarrantsoptionsAmount`	$3.10M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$645.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$198.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$430.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$870.00K	USD	Annual
Issuance of warrants for claim settlement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.62M	USD	Annual
Conversion of debts into common stock, Amount	`ConversionOfDebtsIntoCommonStockAmount`	$27.00K	USD	Annual
Issuance of stock, Amount	`StockIssuedDuringPeriodValueIssuedForCash`	$162.00K	USD	Annual
Deemed dividends	`DeemedDividends`	-	USD	Annual
Acquisition of minority interest	`AdjustmentToAdditionalPaidInCapitalAcquistionOfMinorityInterest`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.35M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.01M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.64M	USD	Annual
Ending Balance, Amount	`StockholdersEquity`	$1.58M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.01M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$1.13M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.